
    
      A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate
      the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal
      Spray 100mcg for 6 Weeks in Adult and Adolescent Subjects 12 years of Age and Older with
      Perennial Allergic Rhinitis (PAR)
    
  